ESP Webinar Series on Clinical Trials
Part II

23 October 2025
16:00 - 17:00 CEST

This webinar is part of a series: 

Part I: 7 October 2025

Part II: 23 October 2025

Part III: 4 December 2025

More information will be communicated in due time. 

Webinar Overview

  • ESP will be organising a series of three webinars on clinical trials.
  • All webinars will be offered free of charge.
  • The webinars are recorded and will be made available to ESP members via the ESP educational platform.

Save the date for Part III: 

Part III: 4 December 2025, 16:00 – 17:00 CET

Past webinars of this series: 

Part I: 7 October 2025, 16:00 – 17:00 CEST

Faculty

  • Speaker: Dr Dellia Mezzanzanica, Head of Integrated Biology of Rare Tumors at Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
  • Moderators:
    • Prof. José Alejandro Pérez-Fidalgo, Department of Oncology and Hematology, INCLIVA Biomedical Research Institute, Hospital Clinico Universitario, Valencia, Spain
    • Prof. Xavier Matias-Guiu, ESP President
    • Prof. Catarina Eloy, Chair of the ESP Education Subcommittee

Webinar programme

  • Introduction
  • Relevance in the identification of new prognostic and predictive biomarkers
  • Type of biomarkers
  • Strategy for identifying a new biomarker in the context of a Clinical trial.
  • Translational studies
  • Sample management. Practical issues.

Registration

The webinar will be conducted via ZOOM. 

Please click on the below button to register. 

Certificate of attendance

  • ESP members who participate in the live webinar will receive a personalised certificate of participation.
  • The certificates will be disseminated after the completion of all three webinars of this series.
  • To be eligible for a certificate it is not obligatory to attend all three webinars.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.